ClinicalTrials.Veeva

Menu

Genetic Study of Sitosterolemia

N

National Center for Research Resources (NCRR)

Status

Completed

Conditions

Lipid Metabolism, Inborn Errors
Sitosterolemia

Treatments

Procedure: genetic testing

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00004481
NCRR-M01RR01070-0470
MUSC-HR-8022

Details and patient eligibility

About

OBJECTIVES:

I. Identify the genetic defect and fine map the gene that causes sitosterolemia.

Full description

PROTOCOL OUTLINE: Patients, family members, and normal volunteers provide blood samples for genetic studies and may fill out a general health and medication history.

Linkage analysis and microsatellite screening is performed on genomic DNA, especially chromosome 2p21, between microsatellite markers D2S1788 and D2S1352.

Positive results may be reported to the patient and may influence future treatment.

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics--

  • Diagnosis of sitosterolemia Presence of tendon and tuberous xanthomas Premature atherosclerotic disease No family history of premature coronary artery disease Normal or elevated plasma cholesterol levels

OR

  • Family member of patient with sitosterolemia

OR

  • Normal volunteer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems